Barchart on Facebook
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

10X Genomics Inc (TXG)

10X Genomics Inc (TXG)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 15,350,914
  • Shares Outstanding, K 100,359
  • Annual Sales, $ 245,890 K
  • Annual Income, $ -31,250 K
  • 60-Month Beta N/A
  • Price/Sales 66.56
  • Price/Cash Flow N/A
  • Price/Book 41.78
Trade TXG with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate -0.33
  • Number of Estimates 3
  • High Estimate -0.27
  • Low Estimate -0.39
  • Prior Year -0.33
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
118.12 +29.50%
on 09/21/20
166.31 -8.03%
on 10/19/20
+31.07 (+25.49%)
since 09/18/20
3-Month
91.86 +66.51%
on 07/21/20
166.31 -8.03%
on 10/19/20
+59.96 (+64.47%)
since 07/20/20
52-Week
48.78 +213.57%
on 03/23/20
166.31 -8.03%
on 10/19/20
+100.46 (+191.35%)
since 10/18/19

Most Recent Stories

More News
Illumina-CDGN Partner to Create Coronavirus Tracking System

Illumina (ILMN) partners with Australia's CDGN to track the national transmission of the virus causing COVID-19.

ILMN : 320.44 (-0.26%)
QGEN : 52.08 (-0.40%)
FLGT : 35.57 (-3.39%)
TXG : 152.96 (-6.20%)
10x Genomics Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares

10x Genomics, Inc. (NASDAQ: TXG) (the "Company") today announced the closing of its public offering of 4,600,000 shares of its Class A common stock, which included the exercise in full of the underwriters'...

JPM : 100.37 (+0.57%)
TXG : 152.96 (-6.20%)
The Zacks Analyst Blog Highlights: 10x Genomics, Allscripts Healthcare and NextGen Healthcare

The Zacks Analyst Blog Highlights: 10x Genomics, Allscripts Healthcare and NextGen Healthcare

MDRX : 10.51 (-0.10%)
NXGN : 13.60 (+0.74%)
TXG : 152.96 (-6.20%)
3 Med Info Stocks to Improve Portfolio Health Amid Coronavirus Woes

3 Med Info Stocks to Improve Portfolio Health Amid Coronavirus Woes

TXG : 152.96 (-6.20%)
NXGN : 13.60 (+0.74%)
MDRX : 10.51 (-0.10%)
DGX : 123.32 (+2.06%)
CERN : 72.70 (+0.47%)
10x Genomics to Participate in the Morgan Stanley 2020 Healthcare Conference

10x Genomics (Nasdaq: TXG) today announced the company will be participating in the upcoming Morgan Stanley Virtual Healthcare Conference.

MS : 51.47 (+1.02%)
TXG : 152.96 (-6.20%)
10x Genomics: 2Q Earnings Snapshot

PLEASANTON, Calif. (AP) _ 10x Genomics Inc. (TXG) on Tuesday reported a loss of $40.2 million in its second quarter.

TXG : 152.96 (-6.20%)
10x Genomics (TXG) Looks Good: Stock Adds 6.2% in Session

10x Genomics (TXG) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.

SYNH : 59.30 (-0.67%)
TXG : 152.96 (-6.20%)
10x Genomics Becomes First One Medical Customer to Deploy Cohort-Based COVID-19 Employee Testing

Today, 10x Genomics (Nasdaq: TXG) and One Medical (Nasdaq: ONEM) announced the two organizations are partnering to pioneer a path toward the safe return to work by deploying a comprehensive approach to...

MRK : 78.27 (-0.51%)
TXG : 152.96 (-6.20%)
ONEM : 31.10 (+1.90%)
10x Genomics Becomes First One Medical Customer to Deploy Cohort-Based COVID-19 Employee Testing

Today, 10x Genomics (Nasdaq: TXG) and One Medical (Nasdaq: ONEM) announced the two organizations are partnering to pioneer a path toward the safe return to work by deploying a comprehensive approach to...

MRK : 78.27 (-0.51%)
TXG : 152.96 (-6.20%)
ONEM : 31.10 (+1.90%)
Canadian Gold Stocks Outperforming Amidst High Gold Prices

Sector Reports was created as a platform to help investors find the best free Stock Reports on stocks they own. If you are a shareholder or looking to buy (CVE: GLDX), (TSE: AGI) or (TSE: TXG) then we...

AGI.TO : 10.95 (unch)
TXG.TO : 19.52 (-2.45%)
GLDX : 38.82 (-0.18%)
AGI : 8.34 (+0.60%)
TXG : 152.96 (-6.20%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

10x Genomics Inc. is a life science technology company. It develops and sells instruments, consumables and software for analyzing biological systems. 10x Genomics Inc. is based in Pleasanton, California.

See More

Key Turning Points

2nd Resistance Point 169.30
1st Resistance Point 161.13
Last Price 152.96
1st Support Level 148.52
2nd Support Level 144.08

See More

52-Week High 166.31
Last Price 152.96
Fibonacci 61.8% 121.41
Fibonacci 50% 107.54
Fibonacci 38.2% 93.68
52-Week Low 48.78

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar